|
3904
|
BAY-0069
|
Potent covalent PPARγ inverse agonist |
€90.00
|
|
3809
|
BAY-4931
|
Potent covalent PPARγ inverse agonist |
€120.00
|
|
1950
|
CDDO
|
A potent multifunctional anti-tumor agent. PPAR-γ agonist |
€80.00
|
|
2114
|
CP 775146
|
Potent and selective PPARα agonist |
€85.00
|
|
2727
|
Elafibranor
|
Dual PPARα/δ agonist |
€90.00
|
|
2686
|
FH535
|
Dual inhibitor of PPAR and Wnt/β-catenin signaling |
€75.00
|
|
2706
|
FH535 sodium salt
|
Dual inhibitor of PPAR and Wnt/β-catenin signaling |
€80.00
|
|
1628
|
GSK 3787
|
PPARδ antagonist |
€90.00
|
|
1237
|
GW 7647
|
PPARα agonist |
€95.00
|
|
2262
|
GW 9662
|
Selective PPARγ antagonist |
€60.00
|
|
2533
|
Hydroxypioglitazone
|
Active metabolite of Pioglitazone (M-IV), a PPARγ agonist |
€180.00
|
|
2019
|
INT131
|
Selective PPARγ modulator (partial agonist) |
€90.00
|
|
1567
|
KRP 297
|
PPARα agonist; PPARγ agonist |
€110.00
|
|
2814
|
MHY 553
|
PPARα agonist |
€95.00
|
|
3255
|
Pioglitazone hydrochloride
|
PPARγ agonist; antidiabetic drug |
€50.00
|
|
2443
|
Rosiglitazone
|
PPARγ agonist; antidiabetic drug and stem cell differentiator |
€95.00
|
|
3999
|
Saroglitazar magnesium
|
Potent dual PPARα/γ agonist |
€160.00
|
|
1227
|
WY 14643
|
PPARα agonist |
€50.00
|